Euglena Co., Ltd. (2931) Stock Price

Euglena operates diverse businesses centered on Euglena (Japanese name: Midori-mushi), a microalga, leveraging large-scale cultivation technology for food applications. The company has three main business segments: Healthcare, Biofuel, and Other Businesses.

In the Healthcare segment, Euglena develops, manufactures, and sells health foods and cosmetics utilizing Euglena and Chlorella. Specifically, the company operates the food brand "Karada ni Euglena" (Euglena for Your Body), which incorporates Euglena, and skincare cosmetic brands including "one," "CONC," and "akyrise."

In the Biofuel segment, Euglena develops, manufactures, and sells biofuels using microalgae centered on Euglena and industrial waste oil. Euglena is considered to have high potential as a biofuel feedstock because lipid extraction is possible at low cost while avoiding competition with food production.

In Other Businesses, the company pursues business development and research in emerging areas such as sustainable agritech, bioinformatics, and social business. Specific initiatives include utilizing microalgae in fertilizer and feed applications, and deploying the genetic analysis service "Euglena My Health."

Through these businesses, Euglena is advancing efforts toward realizing a sustainable society. Particularly in the Biofuel segment, the company is promoting initiatives toward commercialization and building supply systems domestically and internationally.

Euglena develops diverse businesses based on microalgae euglena, aiming for sustainable growth. Since its founding, the company has expanded operations in healthcare and biofuel sectors under its purpose of "making people and the planet healthy." In 2020, the company adopted "Sustainability First" and has been advancing business development centered on sustainability.

The company's growth strategy is based on "5F Biomass," which involves expanding into five sectors: Food, Fiber, Feed, Fertilizer, and Fuel. Leveraging the nutritional value and functional properties of euglena and paramylon, the company is advancing applications in health foods, cosmetics, animal feed, and fertilizers. The company has also established large-scale, low-cost cultivation technology, enabling the use of euglena as a biofuel feedstock.

In its medium-term management plan, the company aims to rebuild competitiveness centered on research and development capabilities and entrepreneurial spirit, pursuing stable expansion of existing businesses and development of new revenue sources. Specifically, the company is promoting deepening of healthcare operations and commercialization of biofuel business to improve revenue structure. The company targets revenue of 48,000 million yen by 2025 and 60 billion yen in healthcare business by 2030.

To achieve sustainable growth, Euglena is working to streamline its revenue structure, cultivate growth brands, and strengthen manufacturing capabilities. In particular, to enhance competitiveness in the health food and cosmetics market, the company is advancing brand development and expanding its customer base. In the biofuel business, the company is expanding supply destinations and building commercial production systems while promoting research and development related to biomass resource utilization.